LCN2 and kidney injury: Koca et al. found intraperitoneal dexmedetomidine (50 μg/kg post-CLP) decreased acute kidney injury (histology, creatinine, and Neutrophil gelatinase-associated lipocalin (NGAL)) and inflammatory markers (Cytokeratin 18 (CK18); M30) 6 h post-injury [41].